Eric A Adams - Net Worth and Insider Trading
Eric A Adams Net Worth
The estimated net worth of Eric A Adams is at least $9,891 dollars as of 2024-11-06. Eric A Adams is the President & CEO of InMed Pharmaceuticals Inc and owns about 43,959 shares of InMed Pharmaceuticals Inc (INM) stock worth over $9,891. Details can be seen in Eric A Adams's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Eric A Adams has not made any transactions after 2024-02-20 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Eric A Adams
Eric A Adams Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Eric A Adams owns 1 companies in total, including InMed Pharmaceuticals Inc (INM) .
Click here to see the complete history of Eric A Adams’s form 4 insider trades.
Insider Ownership Summary of Eric A Adams
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| INM | InMed Pharmaceuticals Inc | 2024-02-20 | director & President & CEO |
Eric A Adams Latest Holdings Summary
Eric A Adams currently owns a total of 1 stock. Eric A Adams owns 43,959 shares of InMed Pharmaceuticals Inc (INM) as of February 20, 2024, with a value of $9,891.
Latest Holdings of Eric A Adams
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| INM | InMed Pharmaceuticals Inc | 2024-02-20 | 43,959 | 0.23 | 9,891 |
Holding Weightings of Eric A Adams
Eric A Adams Form 4 Trading Tracker
According to the SEC Form 4 filings, Eric A Adams has made a total of 5 transactions in InMed Pharmaceuticals Inc (INM) over the past 5 years, including 5 buys and 0 sells. The most-recent trade in InMed Pharmaceuticals Inc is the acquisition of 41,600 shares on February 20, 2024, which cost Eric A Adams around $14,976.
Insider Trading History of Eric A Adams
- 1
Eric A Adams Trading Performance
GuruFocus tracks the stock performance after each of Eric A Adams's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Eric A Adams is -33.76%. GuruFocus also compares Eric A Adams's trading performance to market benchmark return within the same time period. The performance of stocks bought by Eric A Adams within 3 months outperforms 0 times out of 5 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Eric A Adams's insider trading performs compared to the benchmark.
Performance of Eric A Adams
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -8.99 | | | | | |
| Relative Return to S&P 500(%) | -8.66 | | | | | |
Eric A Adams Ownership Network
Ownership Network List of Eric A Adams
Ownership Network Relation of Eric A Adams
Eric A Adams Owned Company Details
What does InMed Pharmaceuticals Inc do?
Who are the key executives at InMed Pharmaceuticals Inc?
Eric A Adams is the director & President & CEO of InMed Pharmaceuticals Inc. Other key executives at InMed Pharmaceuticals Inc include Sr VP & Clinical Reg Affairs Mancini Alexandra Diane Janet , Interim CFO Jonathan Tegge , and VP & Accounting and Controller Sarah Li .
InMed Pharmaceuticals Inc (INM) Insider Trades Summary
Over the past 18 months, Eric A Adams made 1 insider transaction in InMed Pharmaceuticals Inc (INM) with a net purchase of 41,600. Other recent insider transactions involving InMed Pharmaceuticals Inc (INM) include a net purchase of 37,500 shares made by Andrew Hull , a net sale of 240 shares made by Mancini Alexandra Diane Janet ,
In summary, during the past 3 months, insiders sold 0 shares of InMed Pharmaceuticals Inc (INM) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 240 shares of InMed Pharmaceuticals Inc (INM) were sold and 79,100 shares were bought by its insiders, resulting in a net purchase of 78,860 shares.
InMed Pharmaceuticals Inc (INM)'s detailed insider trading history can be found in Insider Trading Tracker table.
InMed Pharmaceuticals Inc Insider Transactions
Eric A Adams Mailing Address
Above is the net worth, insider trading, and ownership report for Eric A Adams. You might contact Eric A Adams via mailing address: C/o Inmed Pharmaceuticals Inc., Suite 310 - 815 Hastings Street, Vancouver A1 V6c 1b4.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
